Client News
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
20th July 2020
Paion AG: U.S. license agreement for BYFAVO (remimazolam) between PAION and Cosmo assigned from Cosmo to Acacia
15th July 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
8th July 2020
HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors
7th July 2020
Rentschler Biopharma SE: The key to tackling drug development complexity: Collaboration. Rentschler Biopharma and Vetter team up with joint goal to simplify
6th July 2020
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
2nd July 2020
PAION announces U.S. FDA Approval of remimazolam (BYFAVOTM) for the induction and maintenance of procedural sedation
2nd July 2020
Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target
30th June 2020
There is no more content to load